India, July 11 -- The Alzheimer's Association International Conference (AAIC) 2026 will convene July 12-15 at ExCel London, bringing together scientists, clinicians, and industry stakeholders for the largest international meeting dedicated to advancing dementia research.
Alzheimer's disease is a progressive neurodegenerative disorder marked by memory loss, cognitive decline, and functional impairment. As the most common cause of dementia, it affects millions worldwide and presents significant medical, social, and economic challenges. Current research emphasizes disease-modifying therapies targeting amyloid and tau pathologies, alongside innovations in diagnostics and care delivery.
For comments and feedback contact: editorial@rttnews.com...